Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 4Active not recruiting 3Recruiting 2Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Pancreatic Neoplasms 24Breast Neoplasms 13Triple Negative Breast Neoplasms 10Carcinoma, Non-Small-Cell Lung 4Neoplasm Metastasis 3Thymoma 2Stomach Neoplasms 2Squamous Cell Carcinoma of Head and Neck 2Nasopharyngeal Carcinoma 2Locally Advanced Pancreatic Cancer 2Borderline Resectable Pancreatic Cancer 2Biliary Tract Neoplasms 2Advanced Pancreatic Cancer 2Advanced Gastric Cancer 2Uterine Cervical Neoplasms 1Thromboembolism 1Thoracic Neoplasms 1Stage IV Gastric Cancer With Metastasis 1Stage IA Pancreatic Adenocarcinoma 1Squamous Cell Carcinoma of Lung 1Small Cell Lung Carcinoma 1Resectable Biliary Tract Cancer 1Pathologic Complete Response 1Parkinson Disease 4, Autosomal Dominant Lewy Body 1Pancreatic Ductal Adenocarcinoma 1Muscle-Invasive Bladder Carcinoma 1Melanoma 1Lung Diseases 1Locally Advanced or Metastatic Gastric Adenocarcinoma 1Locally Advanced Cervical Carcinoma 1

Interventions

camrelizumab 3pembrolizumab 2Radiosurgery 2sinoporphyrin sodium 1penpulimab 1apatinib 1Tramadol 1S 1 (combination) 1Poly(ADP-ribose) Polymerase Inhibitors 1Photochemotherapy 1Pemetrexed 1Paclitaxel 1Morphine 1Injections 1Immune Checkpoint Inhibitors 1130-nm albumin-bound paclitaxel 11-phenyl-3,3-dimethyltriazene 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Parkinson Disease 4, Autosomal Dominant Lewy Body × 130-nm albumin-bound paclitaxel × Clear all
NCT04530227 2020-11-13

Camrelizumab With Chemotherapy in Adults With Medically Inoperable Early Stage NSCLC

Tianjin Medical University Cancer Institute and Hospital

Phase 2 Unknown
30 enrolled

Parkinson Disease 4, Autosomal Dominant Lewy Body

Data powered by HemOnc (CC BY 4.0) Colophon âš¡